Green Ammonia Market Research Report 2025-2032, Global Industry Valued at US$ 291.89 Million in 2024 with Exceptional CAGR of 67.98% to Reach US$ 18.33 Billion by 2032

Green Ammonia Market Research Report 2025-2032, Global Industry Valued at US$ 291.89 Million in 2024 with Exceptional CAGR of 67.98% to Reach US$ 18.33 Billion by 2032 Emerging opportunities are accelerating for green ammonia as a hydrogen carrier, as liquid ammonia offers ~12.7 MJ/L volumetric energy density vs ~8.5 MJ/L for liquid hydrogen, making storage […]

Introducing Optimove Loyalty — Empowering Marketers to Reduce Bonus Dependency and Drive Long-Term Player Engagement

Barcelona, Jan. 19, 2026 (GLOBE NEWSWIRE) — As iGaming and sports betting operators face mounting pressure to reduce reliance on costly bonusing while driving sustained player engagement, Optimove, the creator of Positionless Marketing and the #1 Player Engagement Solution for iGaming and sports betting operators, today announced Optimove Loyalty. The new no-code product enables marketing

Introducing Optimove Loyalty — Empowering Marketers to Reduce Bonus Dependency and Drive Long-Term Player Engagement

Introducing Optimove Loyalty — Empowering Marketers to Reduce Bonus Dependency and Drive Long-Term Player Engagement A new no-code product that empowers marketers to operate as Positionless Marketers: designing, launching, and optimizing gamified loyalty experiences independently, without engineering, while protecting profit margins GlobeNewswire January 19, 2026 Barcelona, Jan. 19, 2026 (GLOBE NEWSWIRE) — As iGaming and

Hilbert Group Receives Second Allocation from One of the World’s Leading Sovereign Wealth Funds

STOCKHOLM, SE / ACCESS Newswire / January 19, 2026 / Hilbert Group AB (Nasdaq:HILB B)(STO:HILB-B)(FRA:999), a leading investment firm focused on bridging traditional and digital assets, today announced that it has received a second allocation from one of the world’s leading sovereign wealth funds. The allocations to date form part of an ongoing deployment into

ZS named a Leader and top-ranked in Everest Group’s 2025 Life Sciences AI and Analytics Services PEAK Matrix(R) assessment

EVANSTON, Ill., Jan. 19, 2026 (GLOBE NEWSWIRE) — Everest Group has named ZS a Leader in its 2025 Life Sciences AI and Analytics Services for Commercial PEAK Matrix(R), positioning the firm highest among evaluated providers. The assessment examines how service partners are applying AI, analytics and consulting capabilities to support commercial functions across the life

ZS named a Leader and top-ranked in Everest Group’s 2025 Life Sciences AI and Analytics Services PEAK Matrix(R) assessment

ZS named a Leader and top-ranked in Everest Group's 2025 Life Sciences AI and Analytics Services PEAK Matrix(R) assessment GlobeNewswire January 19, 2026 EVANSTON, Ill., Jan. 19, 2026 (GLOBE NEWSWIRE) — Everest Group has named ZS a Leader in its 2025 Life Sciences AI and Analytics Services for Commercial PEAK Matrix(R), positioning the firm highest

Asian Financial Forum opens next Monday as the region's first major international financial event of 2026

The 19th Asian Financial Forum (AFF), co-organised by the Hong Kong SAR Government and the Hong Kong Trade Development Council (HKTDC), will take place on Monday, 26 and Tuesday, 27 January 2026 at the Hong Kong Convention and Exhibition Centre (HKCEC). This year's AFF introduces a fresh perspective with the new tagline, 'Finance Empowering Business'.

Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

(TSE:4565.T), Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ(R) Phase 3 trial of daridorexant in South Korea met both primary and secondary efficacy endpoints of subjective total sleep time (sTST), subjective latency to sleep onset

Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea GlobeNewswire January 19, 2026 Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ(R) Phase 3 trial of daridorexant in South Korea met

SUNRATE Announces New Alliance with International Travel Technology Provider Juniper Travel Technology

SUNRATE, the global payment and treasury management platform, today announced a new alliance with international travel-technology provider Juniper Travel Technology, underscoring both companies' commitment to empowering the future of global travel commerce. As part of this joint effort, Juniper will integrate SUNRATE's cross-border payment and commercial card issuing capabilities into its travel-technology ecosystem. This will

Scroll to Top